entertainment -WSS

entertainment

author：comprehensive 2025-09-28 02:27:23 - browse：89924

A phone screen displays the webpage of Medicare.gov — coverage from STAT — Adobe

Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

But the federal government was not persuaded by the industry’s data or lobbying push. The Biden administration and its Medicare agency decided to stick with their proposals from January on Monday, dealing a blow to an insurance industry that has come to rely on Medicare Advantage for a steady stream of profits.

The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities. The stock prices of the largest Medicare Advantage insurers — UnitedHealth, Humana, CVS Health, and Elevance Health — all fell by at least 4% in after-hours trading.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Texas board proposes rules on abortion law emergency exemption

knowledge

WSS

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Pregnancy discrimination could be enabled by AI

Pfizer plans to depart BIO

Pfizer plans to depart BIO

6 surprising facts about sugar

Texas board proposes rules on abortion law emergency exemption

entertainment

entertainment

leisure time

How to save PrEP access — and even expand it

CRISPR technology availability, affordability needs to be expanded

Medicare details structure of new drug price negotiation program

Radiology is caught between AI's potential and concern for patients

Guidelines to prevent youth baseball injuries need more muscle

Mirador, a new biotech startup, launches with $400 million

In Memoriam: Notable people who died in 2023

After sickle

Malaria cases in Florida and Texas: Here’s what you need to know

Yancopoulos of Regeneron works to expand Dupixent success

focus

Biotech investment managers search for lucrative opportunities

In diabetes hearing, Sanders takes on a new foe: food makers

Steward Health Care expansion into Malta flopped

Chinese researcher claims birth of first gene

Spinal cord stimulation reduces pain in amputees, study finds

Diabetes management: Digital health tools fall short, study says

Wikipedia

knowledge

focus

leisure time